It's happening with all of the minnows in the market today!
We are due for 2 fairly imminent announcements: the first is expected to be the results from the EU trials and the second is the commercial partner.
The first may be delayed due to Prof. Hardings' schedule as he is all over the place at the moment. When I spoke to him about 3 weeks ago, all the results were in and only required analysis for presentation.
The current global economic situation MAY further delay the commercial partner agreement - but who knows. Time will tell.
There is a lot of work going on with TIS and the 'Wound Management Innovation Cooperative Research Centre' (CRC) is going to be an ongoing source of opportunities in wound management.
The CRC is going to be a huge development channel in wound management.
Regards.............
TIS Price at posting:
41.0¢ Sentiment: Hold Disclosure: Held
